A detailed history of Groupe La Francaise transactions in Dexcom Inc stock. As of the latest transaction made, Groupe La Francaise holds 89,195 shares of DXCM stock, worth $5.18 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
89,195
Previous 77,026 15.8%
Holding current value
$5.18 Million
Previous $6.69 Billion 10.26%
% of portfolio
0.08%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$66.46 - $89.53 $808,751 - $1.09 Million
12,169 Added 15.8%
89,195 $6.01 Billion
Q2 2025

Aug 13, 2025

BUY
$59.83 - $87.57 $2.16 Million - $3.17 Million
36,180 Added 88.58%
77,026 $6.69 Billion
Q1 2025

May 14, 2025

BUY
$67.74 - $90.75 $222,729 - $298,386
3,288 Added 8.75%
40,846 $2.84 Billion
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $2.47 Million - $3.04 Million
37,558 New
37,558 $3 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Groupe La Francaise Portfolio

Follow Groupe La Francaise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupe La Francaise, based on Form 13F filings with the SEC.

News

Stay updated on Groupe La Francaise with notifications on news.